These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 6769160

  • 1. [Post-transfusion hepatitis].
    Frey-Wettstein M.
    Schweiz Med Wochenschr Suppl; 1980; (10):1-40. PubMed ID: 6769160
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Laboratory tests in Japanese Red Cross Blood Centers to prevent transfusion-transmitted diseases].
    Watanabe J.
    Rinsho Byori; 1991 Mar; Suppl 88():60-9. PubMed ID: 1906951
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of HB Ag and HB Ab in the Canadian blood-donor population.
    Moore BP.
    Haematologia (Budap); 1974 Mar; 8(1-4):409-13. PubMed ID: 4461428
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Serum hepatitis in donors and recipients].
    Khazanov AI, Stulov AP, Korolev SS, Ivlev AS, Verteletskiĭ VV.
    Voen Med Zh; 1978 Dec; (12):41-3. PubMed ID: 734959
    [No Abstract] [Full Text] [Related]

  • 7. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
    Vyas GN, Perkins HA.
    N Engl J Med; 1982 Mar 25; 306(12):749-50. PubMed ID: 6801510
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Letter: Posttransfusion hepatitis in Kuala Lumpur.
    Kamath S, Lopez CG.
    Med J Aust; 1973 Nov 03; 2(18):867-8. PubMed ID: 4782397
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis.
    Hollinger FB, Aach RD, Gitnick GL, Roche JK, Melnick JL.
    N Engl J Med; 1973 Aug 23; 289(8):385-91. PubMed ID: 4719826
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J, Constantoulakis M, Augustaki O, Taylor PE, Zuckerman AJ, Baines PM, Bryceson MA.
    Vox Sang; 1970 Aug 23; 19(3):401-3. PubMed ID: 4993791
    [No Abstract] [Full Text] [Related]

  • 18. Does blood with antibodies against hepatitis B carry an increased risk to transmit hepatitis.
    Vox Sang; 1975 Aug 23; 28(6):460-7. PubMed ID: 1146274
    [No Abstract] [Full Text] [Related]

  • 19. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.
    Transfusion; 2005 Oct 23; 45(10):1670-5. PubMed ID: 16181219
    [Abstract] [Full Text] [Related]

  • 20. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B, Verma M, Verma K.
    Jpn J Infect Dis; 2004 Apr 23; 57(2):49-51. PubMed ID: 15118208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.